2019 International Congress

September 22-26, 2019. Nice, France.

View by Title View Sessions

View by Date

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Unscheduled disruption of Deep Brain Stimulation (DBS) in Parkinson’s Disease (PD)

A. Blain, O. Lagha-Boukbiza, O. Gebus, M. Anheim, C. Tranchant (Strasbourg, France)
Unusual expression of fragile X premutation in a female patient: clinical and tractographic description

V. Ros-Castelló, E. Natera-Villalba, A. Sánchez-Sánchez, A. Gómez-López, P. Pérez-Torre, S. Fanjul, J. López-Sendón, A. Alonso-Cánovas, JC. Martínez-Castrillo, J. álvarez-Linera, I. Pareés (Madrid, Spain)
Update from the international MDSGene initiative: International team science to perform genotype-phenotype correlations for hereditary movement disorders

S. Petkovic, S. Schaake, J. Huang, H. Madoev, A. Rasheed, K. Lohmann, C. Klein, C. Marras (Luebeck, Germany)
Urodynamic study to distinguish multiple system atrophy from Parkinson’s disease

KW. Park, JH. Shin, NR. Choi, SY. Jo, MS. Choo, SJ. Chung (Seoul, Republic of Korea)
Use digital sensor and deep learning to evaluate motor performance in the D1PAM (LY3154207) phase 1B Parkinson’s disease clinical trial

Y. Li, Y. Guan, J. Wang, A. Calvin, J. Kyle, B. Miller (Indianapolis, IN, USA)
Use of Chemodenervation for Secondary Limb Dystonia in Parkinson’s Disease: A Single Center Experience

V. Veerappan, M. Brodsky (Portland, OR, USA)
Use of directional stimulation to localize and troubleshoot STN-related contralateral gaze deviation: a case report

C. Stahl, C. Cho, A. Mogilner, M. Pourfar (New York, NY, USA)
Use of e-PROMs in Parkinson’s disease clinics: A qualitative study of healthcare professionals perceptions

A. Khardali, L. Hughes, E. Lane (Cardiff, United Kingdom)
Use of Inappropriate Antipsychotics Among US Long-Term Care Residents with Parkinson’s Disease Psychosis

D. Kremens, V. Abler, S. Andes, N. Rashid, A. Shim (Philadelphia, PA, USA)
Use of ß2-adrenoreceptor agonist and antagonist drugs and risk of Parkinson’s disease

F. Hopfner, M. Wod, G. Höglinger, M. Blaabjerg, T. Roesler, G. Kuhlenbäumer, K. Christensen, G. Deuschl, A. Pottegård (Kiel, Germany)

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z